Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn's disease: data from CALM


Panaccione R., Colombel J., Bossuyt P., Baert F., Vanasek T., Danalioglu A., ...More

JOURNAL OF CROHNS & COLITIS, vol.12, 2018 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 12
  • Publication Date: 2018
  • Journal Name: JOURNAL OF CROHNS & COLITIS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bezmialem Vakıf University Affiliated: Yes